¼¼°èÀÇ °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå
Buccal Drug Delivery Systems
»óǰÄÚµå : 1777894
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 368 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,180,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,541,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

°æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 58¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 43¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 5.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 58¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Buccal Tablets & Lozenge´Â CAGR 5.9%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á±îÁö 27¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼³ÇÏ Çʸ§£¦¿þÀÌÆÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£Áß CAGR 4.5%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 12¾ï ´Þ·¯·Î ÃßÁ¤¡¤¿¹Ãø, Áß±¹Àº CAGR 8.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀº 2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 12¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 8.1%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 2.3%¿Í 5.0%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.2%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¼¼°èÀÇ °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

°æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛÀ̶õ ¹«¾ùÀ̸ç, ¿Ö Çö´ë ÀÇÇп¡¼­ Áß¿äÇѰ¡?

°æ±¸¿ë ¾à¹°Àü´Þ½Ã½ºÅÛÀº »´ ¾ÈÂÊÀÇ ÇùÃø Á¡¸·À» ÅëÇØ Åõ¿©Çϵµ·Ï ¼³°èµÈ ÀǾàǰ Á¦Á¦ÀÔ´Ï´Ù. ÀÌ °æ·Î´Â ¼ÒÈ­°üÀ̳ª °£¿¡¼­ÀÇ 1Â÷ ´ë»ç¸¦ ¿ìȸÇÏ¿© Àü½Å ¼øÈ¯¿¡ Á÷Á¢ ¾à¹°À» Èí¼öÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇùºÎ¸¦ ÅëÇÑ ¾à¹°Àü´ÞÀº ºü¸¥ ¾àÈ¿ ¹ßÇö, »ýüÀÌ¿ë·ü Çâ»ó, Åõ¿© ¿ëÀ̼º µî ¿©·¯ °¡Áö ÀåÁ¡ÀÌ ÀÖ¾î »ïŰ±â ¾î·Á¿î ȯÀÚ³ª ºü¸¥ ¾à¹°À» ÇÊ¿ä·Î Çϴ ȯÀÚ¿¡°Ô ÀÌ»óÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡´Â Á¤Á¦, Çʸ§, ÆÐÄ¡, ½ºÇÁ·¹ÀÌ, Á© µî ´Ù¾çÇÑ ÇüŰ¡ ÀÖÀ¸¸ç, ¾à¹°À» Áö¼ÓÀûÀ¸·Î ¹æÃâÇϱâ À§ÇØ Á¡¸· Ç¥¸é¿¡ ºÎÂøÇÏ¿© ¾à¹°À» Áö¼ÓÀûÀ¸·Î ¹æÃâÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. Çù½ÉÁõ Ä¡·áÁ¦ÀÎ ´ÏÆ®·Î±Û¸®¼¼¸°, ÁøÅëÁ¦ÀÎ ÆæÅ¸´Ò, Àν¶¸°, È£¸£¸ó ¿ä¹ý, ¹é½Å, Àü½Å ÁúȯÀÇ Ä¡·á µî ´Ù¾çÇÑ ¾à¹°À» »´¿¡ Åõ¿©ÇÏ´Â °ÍÀÌ ÀϹÝÀûÀÔ´Ï´Ù. ºñħ½ÀÀû Ư¼º°ú ÆíÀǼºÀ¸·Î ÀÎÇØ ±âÁ¸ÀÇ °æ±¸ ¹× ÁÖ»ç °æ·Î¸¦ ´ëüÇÒ ¼ö ÀÖ´Â ¸Å·ÂÀûÀÎ ´ë¾ÈÀÌ µÇ°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼ú Çõ½ÅÀº °æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛÀ» Å©°Ô ¹ßÀü½ÃÄÑ ¾à¹°ÀÇ ¾ÈÁ¤¼º, Èí¼öÀ², ȯÀÚ ¼øÀÀµµ¸¦ Çâ»ó½ÃÄ×½À´Ï´Ù. Á¡Âø¼º Æú¸®¸ÓÀÇ °³¹ß·Î Á¦Á¦°¡ ÇùÃø Á¡¸·¿¡ Á¢ÂøÇÏ´Â ´É·ÂÀÌ °­È­µÇ¾î Á¢ÃË ½Ã°£À» ¿¬ÀåÇÏ°í ¾à¹° ¹æÃâÀ» Á¦¾îÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ³ª³ë±â¼úÀº ¾à¹°Àü´ÞÀÇ ÃÖÀûÈ­¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ³ª³ëÀÔÀÚ¿Í ¸®Æ÷Á»Àº ¿ëÇØµµ, »ýü ÀÌ¿ë·ü, Ç¥Àû Àü´ÞÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ħÅõ ÃËÁøÁ¦ÀÇ ¹ßÀüÀ¸·Î ÆéŸÀ̵å, ´Ü¹éÁú µî ±âÁ¸¿¡´Â Á¡¸· À庮À» ³Ñ±â ¾î·Á¿ü´ø °íºÐÀÚÀÇ Èí¼ö°¡ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, 3D ÇÁ¸°ÆÃ ±â¼úÀº ¿ë·®°ú ¹æÃâ ÇÁ·ÎÆÄÀÏÀ» Á¤¹ÐÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ´Â ÇùÃø ¾à¹°Àü´Þ ÀåÄ¡¸¦ ¸ÂÃãÈ­ÇÒ ¼ö ÀÖ´Â µµ±¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾à¹° ¹æÃâ°ú ȯÀÚÀÇ º¹¾à ¼øÀÀµµ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ´Â ¼¾¼­°¡ ³»ÀåµÈ ½º¸¶Æ® ¾à¹°Àü´Þ ½Ã½ºÅÛ °³¹ßµµ ÁøÇà ÁßÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀû ºñ¾àÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇØ ´Ù¾çÇÑ Ä¡·á ¿µ¿ª¿¡¼­ ÇùÃøÀ» ÅëÇÑ ¾à¹°Àü´ÞÀÇ Àû¿ë °¡´É¼ºÀÌ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù.

°æ±¸¿ë ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ÇöÀç µ¿ÇâÀº?

ºñħ½ÀÀûÀ̰í ȯÀÚ Ä£È­ÀûÀÎ ¾à¹° Åõ¿© ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ »´À» ÅëÇÑ ¾à¹°Àü´Þ ½ÃÀåÀº ¿ªµ¿ÀûÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó ¸ÂÃãÇü Åõ¿© ¿É¼ÇÀ» Á¦°øÇÏ´Â ÇùÃø Åõ¿© ½Ã½ºÅÛÀÌ ÁÖ¸ñ¹Þ°í ÀÖ½À´Ï´Ù. »ý¹°ÇÐÀû Á¦Á¦ ¹× ÆéŸÀÌµå ±â¹Ý ¾à¹°ÀÇ ºÎ»óÀ¸·Î ÀÎÇØ, ƯÈ÷ Àå±â Ä¡·á°¡ ÇÊ¿äÇÑ ¸¸¼º ÁúȯÀÇ °æ¿ì, Áֻ縦 ´ëüÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ¸·Î »´À» ÅëÇÑ ¾à¹°Àü´Þ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦¾à¾÷°è´Â ¹é½Å, À¯ÀüÀÚÄ¡·áÁ¦, Ä«³ªºñ³ëÀÌµå µî »õ·Î¿î Ä¡·áÁ¦¸¦ »´¿¡ Åõ¿©ÇÏ´Â ¹æ¹ýÀ» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚ°¡ Åõ¾à ¹× ÀçÅÃÄ¡·á Æ®·»µåµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹Àº ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ´Â °¡´É¼ºÀ» ÀνÄÇϰí, °£¼ÒÈ­µÈ ½ÂÀÎ °æ·Î¸¦ ÅëÇØ ¹éÇ÷±¸ Á¦Á¦ °³¹ßÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. Áö¼Ó°¡´É¼º ¶ÇÇÑ »õ·Î¿î Æ®·»µåÀ̸ç, ģȯ°æ Æ÷Àå°ú »ýºÐÇØ¼º ¼ÒÀç°¡ Á¦Ç° ¼³°è¿¡ µµÀԵǾî ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÁÙÀ̰í ÀÖ½À´Ï´Ù.

°æ±¸ ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµË´Ï´Ù.

°æ±¸¿ë ¾à¹°Àü´Þ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º Áúȯ Áõ°¡, Áï°¢ÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä, ºñħ½ÀÀû ¾à¹°Àü´Þ ¹æ½Ä¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Á¡Âø ±â¼ú, ³ª³ë ij¸®¾î µî Á¦Á¦ °úÇÐÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÇùÃø Á¦Ç°ÀÇ È¿´É°ú ¾ÈÀü¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ °æ±¸¿ë ÀǾàǰÀ¸·Î ¾î·Á¿òÀ» °Þ´Â ³ë·É Àα¸ Áõ°¡´Â ÇùÃø ½Ã½ºÅÛ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »ý¹°ÇÐÀû Á¦Á¦ÀÇ ±ÞÁõ°ú °íºÐÀÚ ¾à¹°ÀÇ È¿À²ÀûÀÎ Àü´ÞÀÇ Çʿ伺À¸·Î ÀÎÇØ Á¾¾çÇÐ, ³»ºÐºñÇÐ, ÅëÁõ °ü¸® µîÀÇ ºÐ¾ß¿¡¼­ ÇùÃø Åõ¿© °æ·ÎÀÇ Àû¿ëÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ÀǾàǰ ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÇÔ²² ±ÔÁ¦ ´ç±¹ÀÇ Áö¿øÀº Á¦Ç° Çõ½Å°ú ½ÃÀå È®´ë¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. °æ±¸¿ë ¾à¹°Àü´ÞÀÇ Æí¸®¼ºÀº ȯÀÚÀÇ ¼øÀÀµµ ¹× Ä¡·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â ÀáÀç·Â°ú ÇÔ²² ¼¼°è Á¦¾à »ê¾÷¿¡¼­ Áß¿äÇÑ ¼ºÀå ºÐ¾ß·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(±¸°­ Á¤Á¦ ¹× ·ÎÁ¨Áö, ¼³ÇÏ Çʸ§ ¹× ¿þÀÌÆÛ, ±¸°­ ½ºÇÁ·¹ÀÌ); ¿ëµµ(±Ý¿¬ ¿ëµµ, ÅëÁõ °ü¸® ¿ëµµ, Çù½ÉÁõ ¿ëµµ, ±âŸ ¿ëµµ); ÃÖÁ¾ ¿ëµµ(º´¿ø ÃÖÁ¾ ¿ëµµ, ¿Ü·¡ ¼¾ÅÍ ÃÖÁ¾ ¿ëµµ, ±âŸ ÃÖÁ¾ ¿ëµµ).

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°è °íÀ¯ SLM¿¡ Äõ¸®-ÇÏ´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ Å¥·¹ÀÌÆ®µÈ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Buccal Drug Delivery Systems Market to Reach US$5.8 Billion by 2030

The global market for Buccal Drug Delivery Systems estimated at US$4.3 Billion in the year 2024, is expected to reach US$5.8 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Buccal Tablets & Lozenges, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Sublingual Films & Wafers segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 8.1% CAGR

The Buccal Drug Delivery Systems market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 8.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Buccal Drug Delivery Systems Market - Key Trends & Drivers Summarized

What Are Buccal Drug Delivery Systems and Why Are They Important in Modern Medicine?

Buccal drug delivery systems are pharmaceutical formulations designed for administration through the buccal mucosa, the inner lining of the cheeks. This route allows for the direct absorption of drugs into the systemic circulation, bypassing the gastrointestinal tract and first-pass metabolism in the liver, which can degrade certain medications. Buccal drug delivery offers several advantages, including rapid onset of action, improved bioavailability, and ease of administration, making it ideal for patients with swallowing difficulties or those requiring fast-acting medication. These systems come in various forms, such as tablets, films, patches, sprays, and gels, designed to adhere to the mucosal surface for sustained drug release. Buccal delivery is commonly used for drugs like nitroglycerin (for angina), fentanyl (for pain management), and insulin, as well as in hormone therapies, vaccines, and treatments for systemic diseases. Its non-invasive nature and convenience make it an attractive alternative to traditional oral and injectable routes.

How Are Technological Advancements Enhancing Buccal Drug Delivery Systems?

Technological innovations have significantly advanced buccal drug delivery systems, improving drug stability, absorption rates, and patient compliance. The development of mucoadhesive polymers has enhanced the ability of formulations to adhere to the buccal mucosa, ensuring prolonged contact time and controlled drug release. Nanotechnology plays a critical role in optimizing drug delivery, with nanoparticles and liposomes improving solubility, bioavailability, and targeted delivery. Advances in permeation enhancers have facilitated the absorption of large molecules, such as peptides and proteins, which traditionally faced challenges in crossing mucosal barriers. 3D printing technology is also emerging as a tool for customizing buccal drug delivery devices, allowing precise control over dosage and release profiles. Furthermore, smart drug delivery systems with integrated sensors are being developed to monitor drug release and patient adherence in real time. These technological breakthroughs are expanding the potential applications of buccal drug delivery across a wide range of therapeutic areas.

What Are the Current Trends in the Buccal Drug Delivery Systems Market?

The buccal drug delivery market is experiencing dynamic growth driven by the increasing demand for non-invasive, patient-friendly drug administration methods. There is a growing focus on personalized medicine, with buccal systems offering customizable dosing options tailored to individual patient needs. The rise of biologics and peptide-based drugs has fueled interest in buccal delivery as an alternative to injections, particularly for chronic conditions requiring long-term treatment. Additionally, the pharmaceutical industry is exploring buccal delivery for novel therapies, including vaccines, gene therapies, and cannabinoids. The trend towards self-administration and home-based healthcare solutions has also contributed to the market’s growth, as buccal systems are easy to use without medical supervision. Regulatory agencies are supporting the development of buccal formulations through streamlined approval pathways, recognizing their potential to improve patient outcomes. Sustainability is another emerging trend, with eco-friendly packaging and biodegradable materials being incorporated into product designs to reduce environmental impact.

The Growth in the Buccal Drug Delivery Systems Market Is Driven by Several Factors…

The growth in the buccal drug delivery systems market is driven by several factors, including the increasing prevalence of chronic diseases, the demand for rapid-onset therapies, and the rising preference for non-invasive drug delivery methods. Technological advancements in formulation science, such as mucoadhesive technologies and nanocarriers, have improved the efficacy and safety of buccal products. The growing geriatric population, which often faces difficulties with traditional oral medications, has further increased demand for buccal systems. Additionally, the surge in biologics and the need for efficient delivery of large-molecule drugs have expanded the application of buccal routes in areas like oncology, endocrinology, and pain management. Regulatory support, coupled with increased investment in pharmaceutical research and development, has accelerated product innovation and market expansion. The convenience of buccal drug delivery, combined with its potential for improved patient compliance and therapeutic outcomes, positions it as a key growth area in the global pharmaceutical landscape.

SCOPE OF STUDY:

The report analyzes the Buccal Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Buccal Tablets and Lozenges, Sublingual Films and Wafers, Oral Sprays); Application (Smoking Cessation Application, Pain Management Application, Angina Pectoris Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â